DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM - Generic Drug Details

What are the generic drug sources for durlobactam sodium; durlobactam sodium; sulbactam sodium and what is the scope of freedom to operate?

Durlobactam sodium; durlobactam sodium; sulbactam sodium is the generic ingredient in one branded drug marketed by Entasis Therap and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Durlobactam sodium; durlobactam sodium; sulbactam sodium has seventy-eight patent family members in forty-two countries.

One supplier is listed for this compound.

Summary for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

International Patents:	78
US Patents:	4
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
DailyMed Link:	DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

Constraining patent/regulatory exclusivity:

GENERATING ANTIBIOTIC INCENTIVES NOW

Dosage:

POWDER;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Anatomical Therapeutic Chemical (ATC) Classes for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

J01CG	Beta-lactamase inhibitors
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes				Y
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes			Y
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes
Entasis Therap	XACDURO (COPACKAGED)	durlobactam sodium; durlobactam sodium; sulbactam sodium	POWDER;INTRAVENOUS	216974-001	May 23, 2023		RX	Yes	Yes

International Patents for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM

Country	Patent Number	Title	Estimated Expiration
Uruguay	34723	?COMPUESTOS DE 7-OXO-1,6-DIAZABICICLO[3.2.1]OCT-3-EN-6-ILO SUSTITUIDOS PARA USARSE COMO INHIBIDORES DE LA BETALACTAMASA?.
Hungary	E036722
Spain	2717776
Spain	2663416
Israel	234660	תרכובות הטרוביציקליות כמעכבות בטא-לקטמאז (Heterobicyclic compounds as beta-lactamase inhibitors)